Alpha Cognition (NASDAQ:ACOG) COO Buys $20,160.00 in Stock

Alpha Cognition Inc. (NASDAQ:ACOG) COO Lauren D’angelo purchased 3,500 shares of the stock in a transaction that occurred on Tuesday, May 19th. The shares were purchased at an average cost of $5.76 per share, with a total value of $20,160.00. Following the completion of the acquisition, the chief operating officer owned 140,695 shares in the company, valued at approximately $810,403.20. This represents a 2.55% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this link.

Alpha Cognition Trading Down 1.2%

ACOG opened at $5.82 on Friday. The company has a fifty day simple moving average of $6.07 and a 200 day simple moving average of $5.90. The firm has a market cap of $126.72 million, a price-to-earnings ratio of -4.31 and a beta of 2.38. Alpha Cognition Inc. has a twelve month low of $4.50 and a twelve month high of $11.54.

Alpha Cognition (NASDAQ:ACOG) last released its quarterly earnings results on Thursday, May 14th. The company reported ($0.37) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.41) by $0.04. The business had revenue of $3.53 million during the quarter, compared to analyst estimates of $3.42 million. Alpha Cognition had a negative net margin of 232.23% and a negative return on equity of 58.35%. On average, analysts forecast that Alpha Cognition Inc. will post -1.34 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

ACOG has been the topic of a number of research analyst reports. HC Wainwright reiterated a “buy” rating and set a $18.00 price objective on shares of Alpha Cognition in a research note on Monday, April 27th. Wall Street Zen downgraded shares of Alpha Cognition from a “hold” rating to a “sell” rating in a research note on Saturday, May 2nd. Finally, Craig Hallum initiated coverage on shares of Alpha Cognition in a research note on Friday, April 17th. They set a “buy” rating and a $14.00 price objective on the stock. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, the company has an average rating of “Buy” and an average price target of $16.00.

Institutional Inflows and Outflows

A number of large investors have recently modified their holdings of ACOG. Geode Capital Management LLC bought a new position in shares of Alpha Cognition in the 2nd quarter worth about $112,000. Marshall Wace LLP bought a new stake in Alpha Cognition in the 2nd quarter valued at about $600,000. Cable Car Capital LP lifted its position in Alpha Cognition by 68.8% in the 2nd quarter. Cable Car Capital LP now owns 869,002 shares of the company’s stock valued at $8,108,000 after purchasing an additional 354,278 shares during the last quarter. Massar Capital Management LP bought a new stake in Alpha Cognition in the 2nd quarter valued at about $116,000. Finally, Manatuck Hill Partners LLC lifted its position in Alpha Cognition by 74.6% in the 2nd quarter. Manatuck Hill Partners LLC now owns 117,000 shares of the company’s stock valued at $1,092,000 after purchasing an additional 50,000 shares during the last quarter.

Alpha Cognition Company Profile

Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.